Advances in nasal trans-mucosal drug delivery

Transmucosal nasal delivery is a promising drug delivery option where common drug administrations, such as intravenous, intramuscular, or oral are inapplicable. Recently, it has been shown that many drugs have better bioavailability by nasal route than the oral route. This has been attributed to rich vasculature and a highly permeable structure of the nasal mucosa coupled with avoidance of hepatic first-pass elimination, gut wall metabolism and/or destruction in the gastrointestinal tract. The physiology of the nose presents obstacles, but offers a promising route for non-invasive systemic delivery of numerous therapies and debatably drug delivery route to the brain. Intranasal microemulsions, gels and microspheres have gained increased interest in recent years as a delivery system for protein and peptides through the nasal route. Thus this review focuses on nasal drug delivery, various aspects of nasal anatomy and physiology, nasal drug absorption mechanisms, various nasal drug delivery systems, and their applications in drug delivery.

[1]  A. Falcão,et al.  Intranasal drug delivery: how, why and what for? , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[2]  Osama H. Mohamed,et al.  Intranasal Microemulsion of Sildenafil Citrate: In Vitro Evaluation and In Vivo Pharmacokinetic Study in Rabbits , 2009, AAPS PharmSciTech.

[3]  A. Babbar,et al.  Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. , 2008, International journal of pharmaceutics.

[4]  F. Alanazi,et al.  Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. , 2008, Drug delivery.

[5]  L. Illum,et al.  Intranasal delivery: physicochemical and therapeutic aspects. , 2007, International journal of pharmaceutics.

[6]  A. Bernkop‐Schnürch,et al.  Transport Characteristics of a Beta Sheet Breaker Peptide Across Excised Bovine Nasal Mucosa , 2007, Drug development and industrial pharmacy.

[7]  P. Diwan,et al.  Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery , 2007, Journal of drug targeting.

[8]  R. Sharma,et al.  Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. , 2006, Journal of pharmaceutical sciences.

[9]  P. Giunchedi,et al.  Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. , 2006, International journal of pharmaceutics.

[10]  T. Kissel,et al.  Insulin Containing Nanocomplexes Formed by Self-Assembly from Biodegradable Amine-Modified Poly(Vinyl Alcohol)-Graft-Poly(l-Lactide): Bioavailability and Nasal Tolerability in Rats , 2005, Pharmaceutical Research.

[11]  R. Sharma,et al.  Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting , 2005, Journal of drug targeting.

[12]  P. Wedlund,et al.  Nipecotic Acid: Systemic Availability and Brain Delivery After Nasal Administration of Nipecotic Acid and n-Butyl Nipecotate to Rats , 2005, Pharmaceutical Research.

[13]  L. Dittert,et al.  Enhancement of the Systemic and CNS Specific Delivery of L-Dopa by the Nasal Administration of Its Water Soluble Prodrugs , 2000, Pharmaceutical Research.

[14]  S. Davis,et al.  Nasal Absorption Enhancers for Biosynthetic Human Growth Hormone in Rats , 1990, Pharmaceutical Research.

[15]  V. D. Hoang,et al.  Characterization of human nasal primary culture systems to investigate peptide metabolism. , 2002, International journal of pharmaceutics.

[16]  A. Mitra,et al.  Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir. , 2001, Journal of pharmaceutical sciences.

[17]  Y. Suzuki,et al.  Mucosal drug delivery using cellulose derivatives as a functional polymer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[18]  V. Dodane,et al.  Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.

[19]  A. Perkins,et al.  Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.

[20]  A. Bernkop‐Schnürch The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[21]  M. Vidgrén,et al.  Nasal delivery systems and their effect on deposition and absorption. , 1998, Advanced drug delivery reviews.

[22]  Romeo,et al.  Optimization of systemic nasal drug delivery with pharmaceutical excipients. , 1998, Advanced drug delivery reviews.

[23]  Krishnamoorthy,et al.  Prodrugs for nasal drug delivery. , 1998, Advanced drug delivery reviews.

[24]  S. Goswami,et al.  Liposomes based nasal delivery system of nifedipine : development and characterization , 1995 .

[25]  M. Miyazaki,et al.  Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats , 1995 .

[26]  H. Striebel,et al.  [Pharmacokinetics of intranasal Fentanyl.]. , 1993, Schmerz.

[27]  K. Ito,et al.  Influence of liposomes on tryptic digestion of insulin. , 1993, Biological & pharmaceutical bulletin.

[28]  M. Hussain,et al.  Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors. , 1990, Journal of pharmaceutical sciences.

[29]  Y. Chien,et al.  Nasal systemic drug delivery , 1989 .

[30]  Clive G. Wilson,et al.  The influence of solution viscosity on nasal spray deposition and clearance , 1988 .

[31]  V. Lee Enzymatic barriers to peptide and protein absorption. , 1988, Critical reviews in therapeutic drug carrier systems.

[32]  G. E. Peters,et al.  Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. , 1987, Journal of pharmaceutical sciences.

[33]  I. Nilsson,et al.  Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. , 1986, Journal of pharmaceutical sciences.

[34]  H. Druce Nasal physiology. , 1986, Ear, nose, & throat journal.

[35]  R. Kimura,et al.  Mechanism of nasal absorption of drugs. II: Absorption of L-tyrosine and the effect of structural modification on its absorption. , 1985, Journal of pharmaceutical sciences.

[36]  Y. Sakakura,et al.  Macromolecular permeability of the tight junction of the human nasal mucosa. , 1985, Rhinology.

[37]  J. Zuidema,et al.  The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas. , 1980, Rhinology.